INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,220,000 | -31.2% | 1,644,813 | -20.5% | 0.00% | -100.0% |
Q3 2016 | $3,226,000 | +23.7% | 2,067,943 | +5.5% | 0.00% | 0.0% |
Q2 2016 | $2,607,000 | -81.8% | 1,960,489 | -28.0% | 0.00% | -66.7% |
Q1 2016 | $14,355,000 | -33.4% | 2,723,919 | -0.8% | 0.00% | -40.0% |
Q4 2015 | $21,559,000 | -8.7% | 2,746,337 | -1.7% | 0.01% | -16.7% |
Q3 2015 | $23,607,000 | -23.3% | 2,793,768 | -0.7% | 0.01% | -14.3% |
Q2 2015 | $30,796,000 | -14.7% | 2,812,412 | +8.9% | 0.01% | -22.2% |
Q1 2015 | $36,100,000 | -12.6% | 2,582,262 | +5.6% | 0.01% | -10.0% |
Q4 2014 | $41,289,000 | +43.1% | 2,444,554 | +13.7% | 0.01% | +25.0% |
Q3 2014 | $28,851,000 | +0.1% | 2,149,839 | -4.9% | 0.01% | 0.0% |
Q2 2014 | $28,813,000 | +27.5% | 2,261,583 | +19.0% | 0.01% | +14.3% |
Q1 2014 | $22,604,000 | -20.1% | 1,901,092 | -7.2% | 0.01% | -22.2% |
Q4 2013 | $28,298,000 | -18.0% | 2,049,092 | +3.5% | 0.01% | -25.0% |
Q3 2013 | $34,495,000 | +18.8% | 1,979,074 | +10.4% | 0.01% | +9.1% |
Q2 2013 | $29,025,000 | – | 1,792,581 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |